Get the Stockscreener App
3.96
3.66%
0.14
Quanterix Corp stock is traded at $3.96, with a volume of 768.44K.
It is up +3.66% in the last 24 hours and down -37.04% over the past month.
Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.
See More
Previous Close:
$3.82
Open:
$3.87
24h Volume:
768.44K
Relative Volume:
1.14
Market Cap:
$185.88M
Revenue:
$138.90M
Net Income/Loss:
$-107.15M
P/E Ratio:
-1.5694
EPS:
-2.5232
Net Cash Flow:
$-79.85M
1W Performance:
-12.39%
1M Performance:
-37.04%
6M Performance:
-24.71%
1Y Performance:
-43.59%
1-Day Range:
$3.87
$4.127
1-Week Range:
$3.64
$4.555
52-Week Range:
$3.64
$8.77
Quanterix Corp Stock (QTRX) Company Profile
Name
Quanterix Corp
Sector
Industry
Phone
617-301-9400
Address
900 MIDDLESEX TURNPIKE, BILLERICA, MA
Compare QTRX vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
QTRX
Quanterix Corp
|
3.96 | 179.31M | 138.90M | -107.15M | -79.85M | -2.5232 |
ABT
Abbott Laboratories
|
104.83 | 182.16B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
327.65 | 125.39B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
87.89 | 112.84B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
69.78 | 103.71B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
82.67 | 48.01B | 6.07B | 1.06B | 1.34B | 1.8063 |
Quanterix Corp Stock (QTRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-11-25 | Downgrade | Canaccord Genuity | Buy → Hold |
| Feb-01-24 | Initiated | Scotiabank | Sector Outperform |
| Sep-25-23 | Upgrade | Canaccord Genuity | Hold → Buy |
| Aug-08-23 | Upgrade | SVB Securities | Market Perform → Outperform |
| May-23-23 | Upgrade | Goldman | Neutral → Buy |
| Aug-15-22 | Downgrade | Canaccord Genuity | Buy → Hold |
| Aug-09-22 | Downgrade | Cowen | Outperform → Market Perform |
| Aug-09-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Mar-02-22 | Upgrade | Goldman | Sell → Neutral |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Jun-04-21 | Initiated | Goldman | Sell |
View All
Quanterix Corp Stock (QTRX) Latest News
Quanterix (QTRX) CLO Daniel Char granted RSUs and stock options - Stock Titan
Quanterix (QTRX) COO gains shares from RSU vesting as stock withheld for taxes - Stock Titan
Quanterix (QTRX) COO Miller details PSUs, RSUs, options and shares in Form 3 - Stock Titan
Quanterix (QTRX) CFO nets common shares from RSU vesting and tax withholding - Stock Titan
Invenomic Capital Management LP Grows Stake in Quanterix Corporation $QTRX - MarketBeat
Risk Report: Whats the MACD signal for Quanterix CorporationRate Cut & Free Real-Time Market Sentiment Alerts - baoquankhu1.vn
Quanterix rises on CMS price for LucentAD Alzheimer blood biomarker test - MSN
Quanterix at Leerink Global Healthcare Conference: Strategic Growth Insights By Investing.com - Investing.com Canada
Quanterix at Leerink Global Healthcare Conference: Strategic Growth Insights - Investing.com
Quanterix at TD Cowen Conference: Strategic Growth and Diagnostics Focus - Investing.com
William Blair Investment Management LLC Increases Holdings in Quanterix Corporation $QTRX - MarketBeat
Quanterix Corporation (NASDAQ:QTRX) Q4 2025 Earnings Call Transcript - Insider Monkey
Quanterix Q4 Earnings Call Highlights - Defense World
Quanterix (QTRX) Revenue Growth Keeps Losses Central To Bulls’ Long-Term Narrative - simplywall.st
Quanterix (QTRX) Q4 2025 Earnings Call Transcript - AOL.com
Quanterix Corporation Q4 2025 Earnings Call Summary - Yahoo Finance
Earnings call transcript: Quanterix Q4 2025 shows revenue beat but EPS miss - Investing.com Australia
Earnings call transcript: Quanterix Q4 2025 shows revenue beat but EPS miss By Investing.com - Investing.com South Africa
Quanterix Corp (QTRX) Q4 2025 Earnings Call Highlights: Revenue Surge Amidst Strategic Shifts - GuruFocus
Quanterix Q4 2025 Earnings Call Transcript - MarketBeat
Quanterix Q4 2025 slides: cost cuts drive path to cash flow breakeven - Investing.com South Africa
Quanterix Corp reports results for the quarter ended December 31Earnings Summary - TradingView
Quanterix earnings missed by $0.06, revenue topped estimates - Investing.com Canada
Quanterix Corporation (QTRX) Reports Q4 Loss, Beats Revenue Estimates - Yahoo Finance
Quanterix (QTRX) Releases Revenue and Margin Projections for 202 - GuruFocus
Quanterix Corporation (QTRX) Releases Q4 2025 Earnings: Revenue Beats but EPS Slightly Misses - Quiver Quantitative
Quanterix (NASDAQ:QTRX) Releases Earnings Results, Misses Expectations By $0.11 EPS - MarketBeat
Quanterix Corporation 8-K Filing Analysis - TradingView
Quanterix (QTRX) grows Q4 revenue, deepens 2025 loss, eyes 2026 cash breakeven - Stock Titan
Quanterix Earnings Report: Q4 Overview - Benzinga
Alzheimer’s blood test heads to 15,000 community events a year - Stock Titan
Quanterix (QTRX) Set to Announce Q4 Earnings with Revenue Growth Expected - GuruFocus
Quanterix (QTRX) to Release Earnings on Monday - Defense World
Quanterix Corp expected to post a loss of 45 cents a shareEarnings Preview - TradingView
Earnings Outlook For Quanterix - Benzinga
Quanterix Corp (QTRX) Q4 2025 Earnings Report Preview: What To L - GuruFocus
Quanterix to Participate in Upcoming Investor Conferences - ChartMill
Envestnet Asset Management Inc. Grows Holdings in Quanterix Corporation $QTRX - Defense World
Biomarker firm Quanterix plans two March investor webcasts - Stock Titan
QTRX Should I Buy - Intellectia AI
Quanterix (QTRX) Expected to Announce Quarterly Earnings on Monday - MarketBeat
Investors can hear Quanterix 2025 results discussed on Mar. 2 call - Stock Titan
Quanterix (NASDAQ:QTRX) Shares Up 0.7%Time to Buy? - MarketBeat
Quanterix Submits FDA 510(k) for Multi-Analyte Alzheimer’s Blood Test - Clinical Lab Products
With 68% ownership, Quanterix Corporation (NASDAQ:QTRX) boasts of strong institutional backing - Yahoo Finance
Quanterix submits FDA 510(k) for multi-analyte Alzheimer's blood test - MSN
Aug Swings: Should value investors consider Quanterix CorporationGlobal Markets & Growth Focused Entry Point Reports - baoquankhu1.vn
Quanterix Submits FDA 510(k) for Multi-Analyte Alzheimer's Blood Test - TradingView
Quanterix (QTRX) Submits Alzheimer's Blood Test for FDA Approval - GuruFocus
Quanterix submits FDA 510(k) for multi-analyte Alzheimer’s blood test - Investing.com
Blood test to spot Alzheimer’s earlier moves to FDA review - Stock Titan
Quanterix Corp Stock (QTRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):